Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision Medicine for Sore/Pain Control
NCT05154695Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2021
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Randomised, open-label trial of dextrose in myofascial pain syndrome (MPS) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Visual Analogue Scale (VAS) - Pain at 4 weeks and Visual Analogue Scale (VAS) - Soreness at 4 weeks. Started Aug 2021; status: completed.
02
Drugs
dextrose
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT05154695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154695.